- Corporate Officers - L
- Lampert Mark N
Insider Trading History of Lampert Mark N
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lampert Mark N since 2016.
This trader's CIK number is 1233840.
At the time of last reporting, Lampert Mark N was the Officer of Essa Pharma Inc.. (stock ticker symbol EPIX).
Also see all insider trading activities at Essa Pharma Inc..
Note that in the past
LAMPERT MARK N also reported insider trading activities as an insider of the following companies:
Insider Activities at Essa Pharma Inc. (EPIX)
Insider Activities at Kymera Therapeutics, Inc. (KYMR)
Insider Activities at Xoma Royalty Corp (XOMA)
Insider Activities at Third Harmonic Bio, Inc. (THRD)
Insider Activities at Moonlake Immunotherapeutics (MLTX)
Insider Activities at Eledon Pharmaceuticals, Inc. (ELDN)
Insider Activities at Point Biopharma Global Inc. (PNT)
Insider Activities at Repare Therapeutics Inc. (RPTX)
Insider Activities at Olema Pharmaceuticals, Inc. (OLMA)
Insider Activities at Rain Oncology Inc. (RAIN)
Insider Activities at Cti Biopharma Corp (CTIC)
Insider Activities at Cullinan Therapeutics, Inc. (CGEM)
Insider Activities at Merus N.v. (MRUS)
Insider Activities at Ideaya Biosciences, Inc. (IDYA)
Insider Activities at Infinity Pharmaceuticals, Inc. (INFI)
Insider Activities at Cytokinetics Inc (CYTK)
Insider Activities at Five Prime Therapeutics, Inc. (FPRX)
Insider Activities at Glycomimetics Inc (GLYC)
Insider Activities at Calithera Biosciences, Inc. (CALA)
Insider Activities at Palvella Therapeutics, Inc. (PVLA)
Insider Activities at Concert Pharmaceuticals, Inc. (CNCE)
Insider Activities at Immune Design Corp. (IMDZ)
Insider Activities at Arqule Inc (ARQL)
Insider Activities at Xenon Pharmaceuticals Inc. (XENE)
Insider Activities at Capstone Therapeutics Corp. (CAPS)
Insider Activities at Alpine Immune Sciences, Inc. (ALPN)
Yearly summary of insider trading at Xoma Royalty Corp (XOMA) by Lampert Mark N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | XOMA | 0 | $0 | 1,043,440 | $27,626,506 | 0 | $0 |
2023 | XOMA | 22,249 | $420,734 | 0 | $0 | 0 | $0 |
2022 | XOMA | 137,260 | $2,390,749 | 0 | $0 | 0 | $0 |
2020 | XOMA | 487,066 | $10,247,353 | 0 | $0 | 0 | $0 |
2019 | XOMA | 401,108 | $8,618,515 | 0 | $0 | 0 | $0 |
2018 | XOMA | 266,229 | $3,829,129 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Xenon Pharmaceuticals Inc. (XENE) by Lampert Mark N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2017 | XENE | 551,180 | $2,048,386 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Infinity Pharmaceuticals, Inc. (INFI) by Lampert Mark N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2021 | INFI | 0 | $0 | 5,848,520 | $24,207,024 | 0 | $0 |
2018 | INFI | 8,102,849 | $13,034,270 | 0 | $0 | 0 | $0 |
2017 | INFI | 1,604,425 | $2,013,942 | 0 | $0 | 0 | $0 |
2016 | INFI | 1,598,716 | $2,086,187 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Merus N.v. (MRUS) by Lampert Mark N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2021 | MRUS | 1,474,180 | $34,389,455 | 3,318,736 | $76,582,405 | 0 | $0 |
2020 | MRUS | 2,610,767 | $36,212,866 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Palvella Therapeutics, Inc. (PIRS) by Lampert Mark N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | PIRS | 0 | $0 | 50,000 | $224,949 | 0 | $0 |
Yearly summary of insider trading at Capstone Therapeutics Corp. (CAPS) by Lampert Mark N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2017 | CAPS | 0 | $0 | 4,341,586 | $260,495 | 0 | $0 |
Yearly summary of insider trading at Glycomimetics Inc (GLYC) by Lampert Mark N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | GLYC | 2,199,349 | $5,858,199 | 0 | $0 | 0 | $0 |
2019 | GLYC | 1,668,746 | $5,309,949 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Rain Oncology Inc. (RAIN) by Lampert Mark N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2022 | RAIN | 3,978,444 | $26,635,387 | 0 | $0 | 0 | $0 |
2021 | RAIN | 1,380,116 | $21,952,282 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Immune Design Corp. (IMDZ) by Lampert Mark N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | IMDZ | 0 | $0 | 902,000 | $1,654,268 | 0 | $0 |
Yearly summary of insider trading at Moonlake Immunotherapeutics (MLTX) by Lampert Mark N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2024 | MLTX | 0 | $0 | 2,000,000 | $100,004,000 | 0 | $0 |
Yearly summary of insider trading at Arqule Inc (ARQL) by Lampert Mark N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | ARQL | 0 | $0 | 5,567,893 | $18,768,435 | 0 | $0 |
Yearly summary of insider trading at Olema Pharmaceuticals, Inc. (OLMA) by Lampert Mark N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2023 | OLMA | 1,505,932 | $14,818,370 | 0 | $0 | 0 | $0 |
2022 | OLMA | 200,000 | $807,000 | 0 | $0 | 0 | $0 |
2021 | OLMA | 739,675 | $6,945,548 | 0 | $0 | 0 | $0 |
2020 | OLMA | 1,135,334 | $21,571,346 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Point Biopharma Global Inc. (PNT) by Lampert Mark N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2023 | PNT | 0 | $0 | 17,161,278 | $213,657,911 | 0 | $0 |
Yearly summary of insider trading at Repare Therapeutics Inc. (RPTX) by Lampert Mark N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2023 | RPTX | 783,709 | $2,821,352 | 0 | $0 | 0 | $0 |
2022 | RPTX | 3,404,080 | $41,398,923 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Eledon Pharmaceuticals, Inc. (ELDN) by Lampert Mark N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2024 | ELDN | 1,927,937 | $0 | 0 | $0 | 0 | $0 |
2023 | ELDN | 1,978,932 | $0 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Kymera Therapeutics, Inc. (KYMR) by Lampert Mark N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | KYMR | 317,167 | $13,955,348 | 0 | $0 | 0 | $0 |
2023 | KYMR | 414,105 | $5,301,258 | 0 | $0 | 0 | $0 |
2022 | KYMR | 1,498,127 | $38,718,066 | 0 | $0 | 0 | $0 |
2021 | KYMR | 544,166 | $25,575,802 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Five Prime Therapeutics, Inc. (FPRX) by Lampert Mark N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | FPRX | 1,085,422 | $5,126,123 | 7,393,340 | $149,249,354 | 0 | $0 |
2019 | FPRX | 3,538,308 | $13,307,688 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Ideaya Biosciences, Inc. (IDYA) by Lampert Mark N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2021 | IDYA | 0 | $0 | 46,409 | $835,362 | 0 | $0 |
2020 | IDYA | 120,527 | $1,722,685 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Cullinan Therapeutics, Inc. (CGEM) by Lampert Mark N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2022 | CGEM | 2,137,296 | $21,295,540 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Essa Pharma Inc. (EPIX) by Lampert Mark N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | EPIX | 0 | $0 | 156 | $292 | 0 | $0 |
Yearly summary of insider trading at Cytokinetics Inc (CYTK) by Lampert Mark N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | CYTK | 0 | $0 | 1,502,984 | $24,681,309 | 0 | $0 |
2019 | CYTK | 342,072 | $3,229,093 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Concert Pharmaceuticals, Inc. (CNCE) by Lampert Mark N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | CNCE | 0 | $0 | 386,289 | $4,134,837 | 0 | $0 |
2017 | CNCE | 331,916 | $5,256,885 | 1,282,856 | $34,188,112 | 0 | $0 |
Yearly summary of insider trading at Alpine Immune Sciences, Inc. (NVLS) by Lampert Mark N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2017 | NVLS | 325,348 | $747,453 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Cti Biopharma Corp (CTIC) by Lampert Mark N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2022 | CTIC | 0 | $0 | 8,500,000 | $52,020,000 | 0 | $0 |
2021 | CTIC | 2,000,000 | $5,000,000 | 0 | $0 | 0 | $0 |
2018 | CTIC | 6,333,333 | $18,999,999 | 0 | $0 | 0 | $0 |
2016 | CTIC | 1,001,327 | $1,218,614 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Third Harmonic Bio, Inc. (THRD) by Lampert Mark N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2024 | THRD | 0 | $0 | 1,000,000 | $14,300,000 | 0 | $0 |
2022 | THRD | 214,063 | $879,584 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Calithera Biosciences, Inc. (CALA) by Lampert Mark N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | CALA | 0 | $0 | 2,283,598 | $13,701,588 | 0 | $0 |
2019 | CALA | 2,716,927 | $7,494,539 | 0 | $0 | 0 | $0 |
Insider trading activities at 26 companies by Lampert Mark N:
1. Xoma Royalty Corp (XOMA)
2. Xenon Pharmaceuticals Inc. (XENE)
3. Infinity Pharmaceuticals, Inc. (INFI)
4. Merus N.v. (MRUS)
5. Palvella Therapeutics, Inc. (PIRS)
6. Capstone Therapeutics Corp. (CAPS)
7. Glycomimetics Inc (GLYC)
8. Rain Oncology Inc. (RAIN)
9. Immune Design Corp. (IMDZ)
10. Moonlake Immunotherapeutics (MLTX)
11. Arqule Inc (ARQL)
12. Olema Pharmaceuticals, Inc. (OLMA)
13. Point Biopharma Global Inc. (PNT)
14. Repare Therapeutics Inc. (RPTX)
15. Eledon Pharmaceuticals, Inc. (ELDN)
16. Kymera Therapeutics, Inc. (KYMR)
17. Five Prime Therapeutics, Inc. (FPRX)
18. Ideaya Biosciences, Inc. (IDYA)
19. Cullinan Therapeutics, Inc. (CGEM)
20. Essa Pharma Inc. (EPIX)
21. Cytokinetics Inc (CYTK)
22. Concert Pharmaceuticals, Inc. (CNCE)
23. Alpine Immune Sciences, Inc. (NVLS)
24. Cti Biopharma Corp (CTIC)
25. Third Harmonic Bio, Inc. (THRD)
26. Calithera Biosciences, Inc. (CALA)
Table 1. Insider trading of Xoma Royalty Corp (XOMA) by Lampert Mark N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-05-16 | XOMA | Sale | 392,723 | 27.10 | 10,642,793 |
2025-01-24 | XOMA | Sale | 650,717 | 26.10 | 16,983,713 |
2023-01-05 | XOMA | Buy | 19,000 | 18.39 | 349,315 |
2023-01-06 | XOMA | Buy | 3,249 | 21.98 | 71,419 |
2022-09-23 | XOMA | Buy | 16,600 | 16.50 | 273,850 |
2022-09-26 | XOMA | Buy | 6,360 | 16.83 | 107,051 |
2022-09-27 | XOMA | Buy | 1,682 | 16.89 | 28,408 |
2022-09-16 | XOMA | Buy | 24,293 | 17.89 | 434,528 |
2022-09-15 | XOMA | Buy | 5,575 | 17.96 | 100,138 |
2022-09-14 | XOMA | Buy | 26,441 | 17.25 | 456,054 |
2022-09-16 | XOMA | Buy | 24,293 | 17.89 | 434,528 |
2022-09-15 | XOMA | Buy | 5,575 | 17.96 | 100,138 |
2022-09-14 | XOMA | Buy | 26,441 | 17.25 | 456,054 |
2020-12-11 | XOMA | Buy | 200,000 | 25.00 | 5,000,000 |
2020-09-21 | XOMA | Buy | 22,328 | 18.39 | 410,500 |
2020-09-22 | XOMA | Buy | 11,951 | 18.45 | 220,448 |
2020-09-23 | XOMA | Buy | 17,089 | 18.20 | 311,019 |
2020-09-04 | XOMA | Buy | 7,737 | 18.77 | 145,231 |
2020-08-31 | XOMA | Buy | 16,005 | 18.48 | 295,788 |
2020-08-28 | XOMA | Buy | 2,044 | 19.17 | 39,187 |
2020-09-01 | XOMA | Buy | 17,572 | 18.87 | 331,513 |
2020-08-25 | XOMA | Buy | 5,687 | 19.75 | 112,289 |
2020-08-24 | XOMA | Buy | 11,683 | 19.31 | 225,587 |
2020-08-21 | XOMA | Buy | 10,805 | 19.32 | 208,774 |
2020-08-18 | XOMA | Buy | 895 | 19.27 | 17,245 |
2020-08-19 | XOMA | Buy | 3,496 | 19.70 | 68,878 |
2020-08-20 | XOMA | Buy | 1,772 | 19.12 | 33,880 |
2020-08-14 | XOMA | Buy | 21,922 | 18.69 | 409,809 |
2020-08-13 | XOMA | Buy | 1,050 | 17.80 | 18,693 |
2020-08-12 | XOMA | Buy | 4,050 | 17.34 | 70,235 |
2020-03-25 | XOMA | Buy | 8,264 | 17.20 | 142,132 |
2020-03-18 | XOMA | Buy | 4,439 | 14.53 | 64,476 |
2020-03-13 | XOMA | Buy | 100,000 | 18.34 | 1,834,100 |
2020-03-16 | XOMA | Buy | 10,164 | 15.73 | 159,920 |
2020-03-17 | XOMA | Buy | 8,113 | 15.73 | 127,649 |
2019-12-19 | XOMA | Buy | 373,195 | 22.00 | 8,210,290 |
2019-05-14 | XOMA | Buy | 13,816 | 14.74 | 203,661 |
2019-05-13 | XOMA | Buy | 3,797 | 14.36 | 54,524 |
2019-05-10 | XOMA | Buy | 10,300 | 14.57 | 150,040 |
2018-12-17 | XOMA | Buy | 25,000 | 14.19 | 354,800 |
2018-12-11 | XOMA | Buy | 9,400 | 14.50 | 136,271 |
2018-12-12 | XOMA | Buy | 2,810 | 14.75 | 41,447 |
2018-12-13 | XOMA | Buy | 24,253 | 14.41 | 349,534 |
2018-12-06 | XOMA | Buy | 10,927 | 14.80 | 161,697 |
2018-12-10 | XOMA | Buy | 18,081 | 14.54 | 262,970 |
2018-12-07 | XOMA | Buy | 32,015 | 14.77 | 472,765 |
2018-11-30 | XOMA | Buy | 4,823 | 14.85 | 71,616 |
2018-12-03 | XOMA | Buy | 806 | 14.90 | 12,009 |
2018-12-04 | XOMA | Buy | 4,171 | 14.99 | 62,514 |
2018-11-29 | XOMA | Buy | 10,016 | 14.93 | 149,538 |
2018-11-28 | XOMA | Buy | 8,288 | 15.11 | 125,264 |
2018-11-27 | XOMA | Buy | 11,396 | 15.24 | 173,675 |
2018-11-19 | XOMA | Buy | 9,771 | 13.93 | 136,061 |
2018-11-20 | XOMA | Buy | 37,482 | 13.68 | 512,716 |
2018-11-21 | XOMA | Buy | 25,000 | 15.00 | 374,900 |
2018-11-15 | XOMA | Buy | 21,141 | 13.31 | 281,365 |
2018-11-16 | XOMA | Buy | 10,849 | 13.82 | 149,987 |
Table 2. Insider trading of Xenon Pharmaceuticals Inc. (XENE) by Lampert Mark N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2017-08-15 | XENE | Buy | 18,858 | 2.41 | 45,485 |
2017-08-14 | XENE | Buy | 41,344 | 2.70 | 111,794 |
2017-06-27 | XENE | Buy | 85,461 | 4.00 | 341,844 |
2017-06-22 | XENE | Buy | 8,263 | 4.00 | 33,052 |
2017-06-21 | XENE | Buy | 12,148 | 4.00 | 48,592 |
2017-06-15 | XENE | Buy | 11,779 | 3.84 | 45,196 |
2017-06-16 | XENE | Buy | 11,034 | 3.85 | 42,480 |
2017-06-19 | XENE | Buy | 3,595 | 3.85 | 13,840 |
2017-06-06 | XENE | Buy | 150,909 | 3.75 | 565,908 |
2017-06-07 | XENE | Buy | 207,789 | 3.85 | 800,195 |
Table 3. Insider trading of Infinity Pharmaceuticals, Inc. (INFI) by Lampert Mark N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2021-01-22 | INFI | Sale | 5,848,520 | 4.14 | 24,207,024 |
2018-12-13 | INFI | Buy | 175,000 | 1.20 | 210,000 |
2018-11-28 | INFI | Buy | 100,000 | 1.30 | 130,000 |
2018-11-19 | INFI | Buy | 1,465,126 | 1.36 | 1,992,571 |
2018-11-21 | INFI | Buy | 4,700 | 1.35 | 6,345 |
2018-11-15 | INFI | Buy | 91,474 | 1.35 | 123,489 |
2018-11-14 | INFI | Buy | 210,250 | 1.34 | 281,735 |
2018-11-13 | INFI | Buy | 604,208 | 1.35 | 815,680 |
2018-06-19 | INFI | Buy | 3,516,560 | 1.65 | 5,802,324 |
2018-06-21 | INFI | Buy | 425,531 | 1.65 | 702,126 |
2018-04-10 | INFI | Buy | 1,010,000 | 2.00 | 2,020,000 |
2018-04-09 | INFI | Buy | 500,000 | 1.90 | 950,000 |
2017-10-04 | INFI | Buy | 653,449 | 1.28 | 839,028 |
2017-10-03 | INFI | Buy | 946,597 | 1.24 | 1,169,047 |
2017-01-03 | INFI | Buy | 4,379 | 1.34 | 5,867 |
2016-12-30 | INFI | Buy | 3,553 | 1.34 | 4,761 |
2016-12-28 | INFI | Buy | 738,848 | 1.34 | 987,100 |
2016-12-16 | INFI | Buy | 434,656 | 1.28 | 556,359 |
2016-12-19 | INFI | Buy | 198,264 | 1.36 | 269,242 |
2016-12-20 | INFI | Buy | 22,001 | 1.35 | 29,811 |
2016-12-01 | INFI | Buy | 148,894 | 1.19 | 176,439 |
2016-12-02 | INFI | Buy | 52,500 | 1.19 | 62,475 |
Table 4. Insider trading of Merus N.v. (MRUS) by Lampert Mark N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2021-10-07 | MRUS | Sale | 985,447 | 27.53 | 27,130,341 |
2021-10-08 | MRUS | Sale | 147,267 | 27.79 | 4,092,108 |
2021-07-02 | MRUS | Sale | 2,186,022 | 20.75 | 45,359,956 |
2021-03-30 | MRUS | Buy | 300,000 | 19.75 | 5,925,000 |
2021-03-22 | MRUS | Buy | 79,500 | 22.75 | 1,808,625 |
2021-03-16 | MRUS | Buy | 250,000 | 23.00 | 5,750,000 |
2021-01-21 | MRUS | Buy | 844,680 | 24.75 | 20,905,830 |
2020-12-18 | MRUS | Buy | 160,000 | 16.05 | 2,568,000 |
2020-09-15 | MRUS | Buy | 146,754 | 11.75 | 1,724,359 |
2020-09-10 | MRUS | Buy | 189,651 | 11.10 | 2,104,746 |
2020-09-03 | MRUS | Buy | 201,906 | 11.17 | 2,255,290 |
2020-06-08 | MRUS | Buy | 87,254 | 15.20 | 1,326,260 |
2020-06-01 | MRUS | Buy | 1,462,510 | 14.00 | 20,475,140 |
2020-01-16 | MRUS | Buy | 278,730 | 16.15 | 4,501,489 |
2020-01-13 | MRUS | Buy | 83,962 | 14.98 | 1,257,582 |
Table 5. Insider trading of Palvella Therapeutics, Inc. (PIRS) by Lampert Mark N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-09-06 | PIRS | Sale | 50,000 | 4.50 | 224,949 |
Table 6. Insider trading of Capstone Therapeutics Corp. (CAPS) by Lampert Mark N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2017-07-14 | CAPS | Sale | 4,341,586 | .06 | 260,495 |
Table 7. Insider trading of Glycomimetics Inc (GLYC) by Lampert Mark N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-11-04 | GLYC | Buy | 1,266,737 | 2.60 | 3,293,516 |
2020-10-30 | GLYC | Buy | 932,612 | 2.75 | 2,564,683 |
2019-09-05 | GLYC | Buy | 1,668,746 | 3.18 | 5,309,949 |
Table 8. Insider trading of Rain Oncology Inc. (RAIN) by Lampert Mark N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2022-11-08 | RAIN | Buy | 1,710,358 | 5.83 | 9,971,387 |
2022-11-08 | RAIN | Buy | 1,710,358 | 5.83 | 9,971,387 |
2022-01-06 | RAIN | Buy | 61,343 | 12.00 | 735,993 |
2022-01-07 | RAIN | Buy | 496,385 | 12.00 | 5,956,620 |
2021-09-21 | RAIN | Buy | 11,033 | 13.94 | 153,833 |
2021-09-13 | RAIN | Buy | 392,269 | 16.49 | 6,468,515 |
2021-07-01 | RAIN | Buy | 317,279 | 15.65 | 4,965,416 |
2021-07-06 | RAIN | Buy | 269,723 | 15.25 | 4,113,275 |
2021-05-24 | RAIN | Buy | 1,361 | 15.89 | 21,633 |
2021-05-21 | RAIN | Buy | 121,986 | 15.94 | 1,944,700 |
2021-05-18 | RAIN | Buy | 191,197 | 16.65 | 3,183,430 |
2021-05-19 | RAIN | Buy | 17,268 | 15.88 | 274,284 |
2021-05-13 | RAIN | Buy | 58,000 | 14.26 | 827,196 |
Table 9. Insider trading of Immune Design Corp. (IMDZ) by Lampert Mark N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-12-04 | IMDZ | Sale | 902,000 | 1.83 | 1,654,268 |
Table 10. Insider trading of Moonlake Immunotherapeutics (MLTX) by Lampert Mark N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2024-10-04 | MLTX | Sale | 2,000,000 | 50.00 | 100,004,000 |
Table 11. Insider trading of Arqule Inc (ARQL) by Lampert Mark N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-05-30 | ARQL | Sale | 1,035,939 | 5.00 | 5,179,695 |
2018-04-18 | ARQL | Sale | 2,230,373 | 3.10 | 6,914,156 |
2018-04-04 | ARQL | Sale | 2,301,581 | 2.90 | 6,674,584 |
Table 12. Insider trading of Olema Pharmaceuticals, Inc. (OLMA) by Lampert Mark N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2023-09-12 | OLMA | Buy | 1,505,932 | 9.84 | 14,818,370 |
2022-06-10 | OLMA | Buy | 200,000 | 4.04 | 807,000 |
2021-11-30 | OLMA | Buy | 739,675 | 9.39 | 6,945,548 |
2020-11-19 | OLMA | Buy | 1,135,334 | 19.00 | 21,571,346 |
Table 13. Insider trading of Point Biopharma Global Inc. (PNT) by Lampert Mark N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2023-12-18 | PNT | Sale | 17,161,278 | 12.45 | 213,657,911 |
Table 14. Insider trading of Repare Therapeutics Inc. (RPTX) by Lampert Mark N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2023-11-02 | RPTX | Buy | 783,709 | 3.60 | 2,821,352 |
2022-06-13 | RPTX | Buy | 149,161 | 12.73 | 1,898,819 |
2022-06-03 | RPTX | Buy | 644,044 | 12.29 | 7,912,724 |
2022-06-06 | RPTX | Buy | 6,869 | 13.21 | 90,753 |
2022-06-02 | RPTX | Buy | 1,186,045 | 11.68 | 13,855,377 |
2022-05-18 | RPTX | Buy | 420,000 | 8.50 | 3,570,000 |
2022-01-19 | RPTX | Buy | 997,961 | 14.10 | 14,071,250 |
Table 15. Insider trading of Eledon Pharmaceuticals, Inc. (ELDN) by Lampert Mark N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2024-05-09 | ELDN | Buy | 1,927,937 | .00 | 0 |
2023-05-05 | ELDN | Buy | 1,978,932 | .00 | 0 |
Table 16. Insider trading of Kymera Therapeutics, Inc. (KYMR) by Lampert Mark N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-06-30 | KYMR | Buy | 317,167 | 44.00 | 13,955,348 |
2023-11-03 | KYMR | Buy | 197,699 | 14.07 | 2,781,427 |
2023-11-02 | KYMR | Buy | 216,406 | 11.64 | 2,519,831 |
2022-08-22 | KYMR | Buy | 545,525 | 26.00 | 14,183,650 |
2022-05-26 | KYMR | Buy | 224,057 | 14.21 | 3,184,074 |
2022-05-27 | KYMR | Buy | 65,369 | 14.78 | 966,349 |
2022-05-20 | KYMR | Buy | 10,100 | 14.00 | 141,389 |
2022-05-05 | KYMR | Buy | 150,000 | 19.60 | 2,939,850 |
2022-05-06 | KYMR | Buy | 100,000 | 19.25 | 1,925,500 |
2022-01-27 | KYMR | Buy | 95,901 | 38.33 | 3,676,077 |
2022-01-31 | KYMR | Buy | 34,408 | 40.70 | 1,400,405 |
2022-01-24 | KYMR | Buy | 272,767 | 37.76 | 10,300,772 |
2021-07-01 | KYMR | Buy | 544,166 | 47.00 | 25,575,802 |
Table 17. Insider trading of Five Prime Therapeutics, Inc. (FPRX) by Lampert Mark N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-11-11 | FPRX | Sale | 7,393,340 | 20.19 | 149,249,354 |
2020-11-04 | FPRX | Buy | 416,562 | 4.88 | 2,034,488 |
2020-11-06 | FPRX | Buy | 30,000 | 4.98 | 149,520 |
2020-10-06 | FPRX | Buy | 345,241 | 5.04 | 1,738,288 |
2020-09-22 | FPRX | Buy | 32 | 3.80 | 121 |
2020-05-14 | FPRX | Buy | 293,587 | 4.10 | 1,203,706 |
2019-12-20 | FPRX | Buy | 515,020 | 4.05 | 2,085,831 |
2019-12-09 | FPRX | Buy | 135,000 | 4.02 | 542,430 |
2019-11-22 | FPRX | Buy | 1,120,010 | 3.40 | 3,808,034 |
2019-11-05 | FPRX | Buy | 968,112 | 4.00 | 3,872,448 |
2019-10-31 | FPRX | Buy | 6,833 | 3.85 | 26,307 |
2019-10-29 | FPRX | Buy | 2,400 | 3.90 | 9,352 |
2019-10-30 | FPRX | Buy | 20,081 | 3.89 | 78,155 |
2019-10-24 | FPRX | Buy | 135,388 | 3.75 | 507,028 |
2019-10-25 | FPRX | Buy | 30,782 | 3.75 | 115,340 |
2019-10-23 | FPRX | Buy | 3,200 | 3.75 | 11,987 |
2019-10-07 | FPRX | Buy | 525,070 | 3.75 | 1,968,487 |
2019-10-08 | FPRX | Buy | 60,412 | 3.68 | 222,497 |
2019-10-04 | FPRX | Buy | 16,000 | 3.74 | 59,792 |
Table 18. Insider trading of Ideaya Biosciences, Inc. (IDYA) by Lampert Mark N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2021-02-02 | IDYA | Sale | 46,409 | 18.00 | 835,362 |
2020-06-30 | IDYA | Buy | 2,531 | 13.32 | 33,702 |
2020-06-19 | IDYA | Buy | 98,264 | 14.39 | 1,414,018 |
2020-06-22 | IDYA | Buy | 19,732 | 13.94 | 274,965 |
Table 19. Insider trading of Cullinan Therapeutics, Inc. (CGEM) by Lampert Mark N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2022-06-01 | CGEM | Buy | 751,396 | 11.00 | 8,264,604 |
2022-05-12 | CGEM | Buy | 1,000,000 | 9.06 | 9,060,000 |
2022-05-13 | CGEM | Buy | 109,900 | 9.13 | 1,003,936 |
2022-04-01 | CGEM | Buy | 276,000 | 10.75 | 2,967,000 |
Table 20. Insider trading of Essa Pharma Inc. (EPIX) by Lampert Mark N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-08-05 | EPIX | Sale | 156 | 1.88 | 292 |
Table 21. Insider trading of Cytokinetics Inc (CYTK) by Lampert Mark N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-12-09 | CYTK | Sale | 430,954 | 18.00 | 7,757,172 |
2020-02-13 | CYTK | Sale | 1,072,030 | 15.79 | 16,924,137 |
2019-12-10 | CYTK | Buy | 223,659 | 9.40 | 2,102,394 |
2019-12-11 | CYTK | Buy | 118,413 | 9.52 | 1,126,699 |
Table 22. Insider trading of Concert Pharmaceuticals, Inc. (CNCE) by Lampert Mark N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-06-10 | CNCE | Sale | 386,289 | 10.70 | 4,134,837 |
2017-12-19 | CNCE | Sale | 1,282,856 | 26.65 | 34,188,112 |
2017-10-19 | CNCE | Buy | 331,916 | 15.84 | 5,256,885 |
Table 23. Insider trading of Alpine Immune Sciences, Inc. (NVLS) by Lampert Mark N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2017-06-20 | NVLS | Buy | 17,806 | 2.25 | 40,063 |
2017-06-07 | NVLS | Buy | 36,900 | 2.28 | 84,168 |
2017-06-05 | NVLS | Buy | 35,750 | 2.29 | 81,903 |
2017-05-30 | NVLS | Buy | 18,900 | 2.30 | 43,394 |
2017-05-31 | NVLS | Buy | 28,100 | 2.25 | 63,140 |
2017-05-18 | NVLS | Buy | 29,886 | 2.30 | 68,737 |
2017-05-17 | NVLS | Buy | 37,372 | 2.30 | 85,918 |
2017-05-19 | NVLS | Buy | 11,600 | 2.30 | 26,679 |
2017-05-09 | NVLS | Buy | 40,000 | 2.29 | 91,519 |
2017-05-10 | NVLS | Buy | 62,000 | 2.35 | 145,452 |
2017-05-11 | NVLS | Buy | 7,034 | 2.34 | 16,480 |
Table 24. Insider trading of Cti Biopharma Corp (CTIC) by Lampert Mark N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2022-08-09 | CTIC | Sale | 8,500,000 | 6.12 | 52,020,000 |
2021-04-01 | CTIC | Buy | 2,000,000 | 2.50 | 5,000,000 |
2018-02-09 | CTIC | Buy | 6,333,333 | 3.00 | 18,999,999 |
2016-01-07 | CTIC | Buy | 633,780 | 1.22 | 771,310 |
2016-01-08 | CTIC | Buy | 367,547 | 1.22 | 447,304 |
Table 25. Insider trading of Third Harmonic Bio, Inc. (THRD) by Lampert Mark N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2024-10-29 | THRD | Sale | 1,000,000 | 14.30 | 14,300,000 |
2022-12-20 | THRD | Buy | 214,063 | 4.11 | 879,584 |
Table 26. Insider trading of Calithera Biosciences, Inc. (CALA) by Lampert Mark N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-05-21 | CALA | Sale | 2,283,598 | 6.00 | 13,701,588 |
2019-11-20 | CALA | Buy | 191,954 | 3.91 | 750,924 |
2019-11-14 | CALA | Buy | 128,488 | 3.37 | 433,004 |
2019-10-29 | CALA | Buy | 1,598,977 | 2.60 | 4,157,340 |
2019-10-30 | CALA | Buy | 797,508 | 2.70 | 2,153,271 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Lampert Mark N
(Officer of Essa Pharma Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.